Bharat Biotech acquires licence for GSK’s Shigella vaccine development
Pharmaceutical Technology
JUNE 13, 2025
The technology utilises outer membrane vesicles (OMVs) to deliver antigens, often eliminating the need for adjuvants while triggering the immune response. Can pharma tariffs “Make America Manufacture Again”? Give your business an edge with our leading industry insights.
Let's personalize your content